GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr. Lal PathLabs Ltd (BOM:539524) » Definitions » EBIT per Share

Dr. Lal PathLabs (BOM:539524) EBIT per Share : ₹73.75 (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Dr. Lal PathLabs EBIT per Share?

Dr. Lal PathLabs's EBIT per Share for the three months ended in Dec. 2024 was ₹17.20. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was ₹73.75.

During the past 12 months, the average EBIT per Share Growth Rate of Dr. Lal PathLabs was 18.30% per year. During the past 3 years, the average EBIT per Share Growth Rate was 8.40% per year. During the past 5 years, the average EBIT per Share Growth Rate was 6.00% per year. During the past 10 years, the average EBIT per Share Growth Rate was 14.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Dr. Lal PathLabs's EBIT per Share or its related term are showing as below:

BOM:539524' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -5.2   Med: 23.8   Max: 41.6
Current: 8.4

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Dr. Lal PathLabs was 41.60% per year. The lowest was -5.20% per year. And the median was 23.80% per year.

BOM:539524's 3-Year EBIT Growth Rate is ranked better than
57.23% of 173 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.2 vs BOM:539524: 8.40

Dr. Lal PathLabs's EBIT for the three months ended in Dec. 2024 was ₹1,436 Mil.


Dr. Lal PathLabs EBIT per Share Historical Data

The historical data trend for Dr. Lal PathLabs's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr. Lal PathLabs EBIT per Share Chart

Dr. Lal PathLabs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.47 49.60 60.90 45.88 64.25

Dr. Lal PathLabs Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.75 15.20 18.70 22.66 17.20

Dr. Lal PathLabs EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Dr. Lal PathLabs's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

EBIT per Share(A: Mar. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=5348.1/83.236
=64.25

Dr. Lal PathLabs's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

EBIT per Share(Q: Dec. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=1436/83.506
=17.20

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹73.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr. Lal PathLabs  (BOM:539524) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Dr. Lal PathLabs EBIT per Share Related Terms

Thank you for viewing the detailed overview of Dr. Lal PathLabs's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr. Lal PathLabs Business Description

Traded in Other Exchanges
Address
12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.

Dr. Lal PathLabs Headlines

No Headlines